General Information
edit

Website	vivendy.ch
Category	BioTech
Phone	+41-61-271 87 80
Email	info@vivendy.ch
Employees
Description	Enzyme Replacement

Offices
edit

Basel, CHE

Peter Merian-Str. 45
Basel, CH-4052, CHE

See nearby companies

People
edit

Dr. Florian Fischer

CFO

Dr. Gertrud Thormann-Huber

Director Clinical and Regulatory Affairs

Dr.Gosse Bruinsma

Executive Director

Funding
edit

TOTAL	$30.5M
FUNDING TOTAL	$30.5M
Venture Round, 1/08 Aescap Venture TVM Capital	$30.5M

Tags
edit

Vivendy Therapeutics
edit

Vivendy Therapeutics Ltd. has developed a specific recombinant human N-acetylgalactosamine-6-sulfatase (rhGALNS) that is specifically modified to improve enzyme activity - enhancing the efficacy of the therapy in MPS IVA significantly

Recent Milestones
edit

Vivendy Therapeutics received $30.5M in Venture Round funding. (1/1/08)

Posted 6/19/09 at 5:30am
Vivendy Therapeutics added Dr. Gertrud Thormann-Huber as Director Clinical and Regulatory Affairs.

Posted 6/19/09 at 5:30am
Vivendy Therapeutics added Dr.Gosse Bruinsma as Executive Director.

Posted 6/19/09 at 5:30am
Vivendy Therapeutics added Dr. Florian Fischer as CFO.

Posted 6/19/09 at 5:30am